Mélanie Langlois

1.5k total citations
42 papers, 772 citations indexed

About

Mélanie Langlois is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mélanie Langlois has authored 42 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 12 papers in Psychiatry and Mental health and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mélanie Langlois's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (11 papers) and Neurobiology of Language and Bilingualism (5 papers). Mélanie Langlois is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (11 papers) and Neurobiology of Language and Bilingualism (5 papers). Mélanie Langlois collaborates with scholars based in Canada, France and United States. Mélanie Langlois's co-authors include Nicolas Dupré, Martine Simard, Alexander D. Crawford, Camila V. Esguerra, Joël Macoir, Pierre Provencher, Antoine Depaulis, Colin Deransart, Vincent Martel‐Sauvageau and J. R. Roy and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Annals of Neurology.

In The Last Decade

Mélanie Langlois

40 papers receiving 763 citations

Peers

Countries citing papers authored by Mélanie Langlois

Since Specialization

Citations

This map shows the geographic impact of Mélanie Langlois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Langlois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Langlois more than expected).

Fields of papers citing papers by Mélanie Langlois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Langlois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Langlois. The network helps show where Mélanie Langlois may publish in the future.

Co-authorship network of co-authors of Mélanie Langlois

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Langlois. A scholar is included among the top collaborators of Mélanie Langlois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Langlois. Mélanie Langlois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long‐term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome 2025 ·Epilepsia ·Ingrid E. Scheffer, Rima Nabbout, Lieven Lagae, Orrin Devinsky, Stéphane Auvin, Elizabeth A. Thiele, Elaine Wirrell, Tilman Polster, Nicola Specchio, Milka Pringsheim, (unknown), Michael Lock, Mélanie Langlois, (unknown), Amélie Lothe, Joseph Sullivan	1
2	Adult Neurogenesis in the Subventricular Zone of Patients with Huntington's and Parkinson's Diseases and following Long‐Term Treatment with Deep Brain Stimulation 2025 ·Annals of Neurology ·(unknown), (unknown), (unknown), (unknown), Stéphan Saïkali, Peter V. Gould, Maxime Richer, Emmanuelle Pourcher, Mélanie Langlois, (unknown), Michel Prudhomme, Léo Cantin, André Parent, Armen Saghatelyan, Martin Parent	2
3	Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine 2023 ·Journal of Ethnopharmacology ·(unknown), (unknown), Mélanie Langlois, Camila V. Esguerra, Jean‐Luc Wolfender, Alexander D. Crawford, Krystyna Skalicka‐Woźniak	16
4	Post-mortem analysis of Parkinson’s disease brains after long-term deep brain stimulation of the subthalamic nucleus 2023 ·Brain stimulation ·(unknown), (unknown), (unknown), Angela M. Noecker, Marie‐Ève Tremblay, Peter V. Gould, Stéphan Saïkali, Mélanie Langlois, Michel Prudhomme, Cameron C. McIntyre, Léo Cantin, (unknown)	1
5	Widespread alterations in microRNA biogenesis in human Huntington’s disease putamen 2022 ·Acta Neuropathologica Communications ·(unknown), (unknown), (unknown), (unknown), Karolina Pircs, Johan Jakobsson, Chantelle F. Sephton, Mélanie Langlois, Isabelle St‐Amour, Sébastien S. Hébert	13
6	Organisation et filières gériatriques en réponse aux besoins des SAU 2021 ·Soins Gérontologie ·(unknown), Mélanie Langlois, Marc Verny, Jacques Boddaert, (unknown)	0
7	Seizing the moment: Zebrafish epilepsy models 2020 ·Neuroscience & Biobehavioral Reviews ·Kinga Gaweł, Mélanie Langlois, Teresa Martins, Wietske van der Ent, Ettore Tiraboschi, Maxime Jacmin, Alexander D. Crawford, Camila V. Esguerra	74
8	Goal management training ® home-based approach for mild cognitive impairment in Parkinson’s disease: a multiple baseline case report 2018 ·Neurocase ·(unknown), (unknown), (unknown), Mélanie Langlois, Nicolas Dupré, Martine Simard	3
9	Cardinal Motor Features of Parkinson’s Disease Coexist with Peak-Dose Choreic-Type Drug-Induced Dyskinesia 2018 ·Journal of Parkinson s Disease ·(unknown), Hung Nguyen, (unknown), Pierre J. Blanchet, Erwan Bézard, Claude Vincent, Mélanie Langlois, Christian Duval	14
10	Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's disease 2016 ·Neurobiology of Aging ·Jay P. Ross, Nicolas Dupré, Yves Dauvilliers, (unknown), Amirthagowri Ambalavanan, Dan Spiegelman, Alexandre Dionne‐Laporte, (unknown), Mélanie Langlois, Michel Boivin, Claire S. Leblond, Patrick A. Dion, Guy A. Rouleau, Ziv Gan‐Or	28
11	Articulatory Changes in Vowel Production following STN DBS and Levodopa Intake in Parkinson’s Disease 2015 ·Parkinson s Disease ·Vincent Martel‐Sauvageau, J. R. Roy, Léo Cantin, Michel Prudhomme, Mélanie Langlois, Joël Macoir	16
12	Smoking history is associated to cognitive impairment in Parkinson's disease 2015 ·Aging & Mental Health ·(unknown), Nicolas Dupré, Mélanie Langlois, Pierre Provencher, Martine Simard	14
13	Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish 2015 ·Epilepsy & Behavior ·Karine Leclercq, Tatiana Afrikanova, Mélanie Langlois, (unknown), Olivia Erin M Buenafe, (unknown), Ann Van Eeckhaut, Peter de Witte, Alexander D. Crawford, Ilse Smolders, Camila V. Esguerra, Rafał M. Kamiński	41
14	Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine 2015 ·PLoS ONE ·(unknown), Angéla Kecskés, Daniëlle Copmans, Mélanie Langlois, Alexander D. Crawford, Berten Ceulemans, Lieven Lagae, Peter de Witte, Camila V. Esguerra	85
15	Impact of theLSVTon vowel articulation and coarticulation in Parkinson’s disease 2015 ·Clinical Linguistics & Phonetics ·Vincent Martel‐Sauvageau, J. R. Roy, Mélanie Langlois, Joël Macoir	40
16	Changes in Vowel Articulation with Subthalamic Nucleus Deep Brain Stimulation in Dysarthric Speakers with Parkinson’s Disease 2014 ·Parkinson s Disease ·Vincent Martel‐Sauvageau, Joël Macoir, Mélanie Langlois, Michel Prudhomme, Léo Cantin, J. R. Roy	14
17	Thirty Days without a Bite: Wernicke?s Encephalopathy in a Patient with Paranoid Schizophrenia 2014 ·Journal of Neurological Disorders ·Mélanie Langlois, (unknown)	7
18	Dentate gyrus and hilus transection blocks seizure propagation and granule cell dispersion in a mouse model for mesial temporal lobe epilepsy 2010 ·Hippocampus ·Johan Pallud, Ute Häussler, Mélanie Langlois, Sophie Hamelin, Bertrand Devaux, Colin Deransart, Antoine Depaulis	41
19	Involvement of the Thalamic Parafascicular Nucleus in Mesial Temporal Lobe Epilepsy 2010 ·Journal of Neuroscience ·Mélanie Langlois, Pierre‐Olivier Polack, (unknown), Olivier David, Stéphane Charpier, Antoine Depaulis, Colin Deransart	48
20	Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors 2004 ·Virology ·Mélanie Langlois, (unknown), (unknown), Marie‐Ève Paré, Michel Ouellet, Jocelyn Roy, Nancy Dumais, Jean-Michel Mesnard, David M. Rothstein, Susan J. Marriott, Michel J. Tremblay, Benoı̂t Barbeau	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact